Oliver Weingärtner: How Do General Practitioners Use Cardiovascular Guidelines?
Oliver Weingärtner, Associate Professor of Medicine at Friedrich-Schiller University Jena, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Medicine adding:
”Just published Open Access in ‘Frontiers in Medicine’
How are guideline recommendations for cardiovascular patients adopted and implemented by general practitioners in Germany?
We surveyed 437 general practitioners—here are the results:
Recommendations from clinical guidelines—particularly those from the German National Disease Management Guidelines (NVL)—enjoy the highest level of acceptance in daily practice
However, frequent criticisms include the often very extensive presentation, alleged ‘lack of practical relevance,’ significant time requirements, ‘contradictory recommendations’ across different guidelines, and variations in validity.
Summaries of key recommendations—especially ‘pocket guidelines’ and regular publications in medical journals—could help support the application of clinical guidelines in practice.”
Title: Evaluation of clinical guideline implementations for cardiovascular diseases by German general practitioners—Results of a web-based survey
Authors: Markus van der Giet, Bernhard Schwaab, Astrid Mayerböck, Konrad Klein, Olaf Randerath, Oliver Weingärtner
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery